[go: up one dir, main page]

PE20160534A1 - Sistema de administracion intrauterina - Google Patents

Sistema de administracion intrauterina

Info

Publication number
PE20160534A1
PE20160534A1 PE2016000513A PE2016000513A PE20160534A1 PE 20160534 A1 PE20160534 A1 PE 20160534A1 PE 2016000513 A PE2016000513 A PE 2016000513A PE 2016000513 A PE2016000513 A PE 2016000513A PE 20160534 A1 PE20160534 A1 PE 20160534A1
Authority
PE
Peru
Prior art keywords
reservoirs
core
administration system
intrauterine delivery
membrane
Prior art date
Application number
PE2016000513A
Other languages
English (en)
Inventor
Manja Ahola
Luder M Fels
Ulrike Fuhrmann
Christine Talling
Katja Prelle
Norbert Schmees
Bernhard Lindenthal
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of PE20160534A1 publication Critical patent/PE20160534A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A61F6/144—Wirelike structures, e.g. loops, rings, spirals with T-configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Se refiere a un sistema de administracion intrauterina que comprende una construccion de cuerpo y dos depositos que comprenden un nucleo o una membrana que encierra el nucleo, donde el nucleo y la membrana consisten en un polimero con una composicion identica o diferente, donde los depositos comprenden un progestageno o un medicamento que presenta actividad progestagenica que se liberan durante un periodo de tiempo prolongado, en un nivel requerido para la anticoncepcion, donde la velocidad y la duracion de la liberacion desde los depositos son diferentes. Aborda los problemas de hemorragias iniciales y hemorragias irregulares asociadas con el uso de sistemas de administracion intrauterina.
PE2016000513A 2013-10-18 2014-10-14 Sistema de administracion intrauterina PE20160534A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361893083P 2013-10-18 2013-10-18
EP13397533 2013-10-21

Publications (1)

Publication Number Publication Date
PE20160534A1 true PE20160534A1 (es) 2016-06-15

Family

ID=49584678

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016000513A PE20160534A1 (es) 2013-10-18 2014-10-14 Sistema de administracion intrauterina

Country Status (19)

Country Link
US (1) US20160262923A1 (es)
EP (1) EP3057573A1 (es)
JP (1) JP2016539088A (es)
KR (1) KR20160072114A (es)
CN (1) CN105636577A (es)
AU (1) AU2014336286A1 (es)
CA (1) CA2927750A1 (es)
CR (1) CR20160176A (es)
CU (1) CU20160051A7 (es)
DO (1) DOP2016000089A (es)
IL (1) IL244508A0 (es)
MA (1) MA38975A1 (es)
MX (1) MX2016004930A (es)
PE (1) PE20160534A1 (es)
PH (1) PH12016500620A1 (es)
SG (1) SG11201601688WA (es)
TN (1) TN2016000134A1 (es)
UY (1) UY35788A (es)
WO (1) WO2015055635A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU201617347S (en) * 2016-12-23 2017-01-23 Jurox Pty Ltd intravaginal device
BR112020005928A2 (pt) * 2017-09-27 2020-10-06 Bayer Oy método para modificar a liberação de um agente terapeuticamente ativo de uma matriz elastomérica.
WO2021102220A1 (en) 2019-11-21 2021-05-27 Coopersurgical, Inc. Packaging systems for implantable devices and related methods
US11338119B2 (en) * 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) * 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
CN112472975B (zh) * 2020-11-19 2022-04-12 华中科技大学 一种宫内药物控释系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107339B (fi) * 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
PL367961A1 (en) * 2001-08-31 2005-03-07 Schering Oy Drug delivery system
DE10145269A1 (de) * 2001-09-14 2003-04-17 Siegfried R Riek Intrauterine Vorrichtung mit einem oder mehreren Pharmakadepots und integrierten Stellmitteln zur Variation der Abgabedosis
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
FI20085277A0 (fi) * 2008-04-02 2008-04-02 Bayer Schering Pharma Oy Kohdunsisäinen järjestelmä
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception

Also Published As

Publication number Publication date
WO2015055635A1 (en) 2015-04-23
EP3057573A1 (en) 2016-08-24
US20160262923A1 (en) 2016-09-15
CU20160051A7 (es) 2016-07-29
MA38975A1 (fr) 2017-11-30
SG11201601688WA (en) 2016-05-30
CA2927750A1 (en) 2015-04-23
JP2016539088A (ja) 2016-12-15
CN105636577A (zh) 2016-06-01
CR20160176A (es) 2016-07-01
MX2016004930A (es) 2016-06-28
DOP2016000089A (es) 2016-09-15
PH12016500620A1 (en) 2016-06-13
AU2014336286A1 (en) 2016-03-24
KR20160072114A (ko) 2016-06-22
TN2016000134A1 (en) 2017-10-06
UY35788A (es) 2015-05-29
IL244508A0 (en) 2016-04-21

Similar Documents

Publication Publication Date Title
PE20160534A1 (es) Sistema de administracion intrauterina
MX2016001621A (es) Dispositivos y metodos de unidades multiples para administracion de farmacos.
EP3407940A4 (en) PURPOSES OF AUTOMATIC DRUG DISPOSAL
MX2017006653A (es) Metodos para modular los niveles de fármaco en plasma mediante el uso de eritrohidroxibupropión.
EP3402548C0 (en) OCCLUSION RESOLUTION IN DRUG DELIVERY DEVICES, SYSTEMS, AND METHODS
CO2019000643A2 (es) Formulaciones gastrorretentivas orales y usos de las mismas
MX2015012367A (es) Dispositivos de suministro de farmacos con un componente permeable al farmaco y metodos.
WO2015069773A8 (en) Devices and methods for continuous drug delivery via the mouth
BR112015032985A2 (pt) Sistema de distribuição de fragrância, dispositivo de distribuição de fragrância e método para operar um sistema de distribuição de fragrância
UY36342A (es) Nuevos derivados de aminoalquilbenzotiazepinas y usos de los mismos
UY31957A (es) Metodo anticonceptivo mejorado
MX378264B (es) Sistema para la entrega de polímeros líquidos para la administración prolongada de fármacos.
MX2016014622A (es) Sistemas de suministro de medicamentos y metodos de uso relacionados.
CL2017000394A1 (es) Composición que contiene cineol para la administración nasal
MX2016001387A (es) Sistema de suministro para agentes activos.
MX2018015985A (es) Composiciones, dispositivos y metodos para el tratamiento del trastorno relacionado con el consumo de alcohol.
AR116501A1 (es) Sistema de suministro de polímero líquido para administración extendida de drogas
EP3389591C0 (en) Medical delivery device
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
CL2015002620A1 (es) Derivados piridin-4-ilo
MX382580B (es) Formulaciones de liberación inmediata disuasivas de abuso que comprenden polisacáridos no celulósicos.
MX2018005456A (es) Capsulas de liberación prolongada recubiertas con película.
CR20140358A (es) Sistema para la administración de fármacos
PE20160850A1 (es) Sistema multiparticulado para administrar drogas
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal